Wednesday, 16 October 2024 | 16:00 - 17:30
Workshop 2: Impact of the European Clinical Trial Regulation
Moderator: Prof. Pierre Van Damme, Vaccinopolis, University of Antwerp
16:00 Welcome by Fran Van Heuverswyn, Flanders Vaccine
16:05 First learnings from the European clinical trial regulation and its impact on research in Belgium | Jessica Van den Broeck, IQVIA (tbc)
16:30 Perspective from a clinical investigator | Isabel Leroux-Roels CEVAC, Ghent University/UZ Ghent
16:45 Perspective from the Belgium National Competent Authority / FAMHP | Nele Steens, FAMHP
17:00 Discussion Panel with the speakers
17:30 Closing
4 speakers
Head of the Centre for the Evaluation of Vaccination @ Vaccinopolis, University of Antwerp
University of Antwerp